Zobrazeno 1 - 10
of 162
pro vyhledávání: '"Metaxalone"'
Publikováno v:
Journal of Advanced Pharmaceutical Technology & Research, Vol 13, Iss 2, Pp 123-127 (2022)
The notable unbiased of this research work was to evaluate the well-being and effectiveness of metaxalone by administering the newly developed test and reference drug. A two-period, two-categorization, crossover bioavailability study in fed condition
Externí odkaz:
https://doaj.org/article/eb3fe1e1cd824d4bad8598b242ff8445
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Asian Journal of Pharmaceutical Sciences, Vol 11, Iss 5, Pp 668-672 (2016)
A simple and rapid method using liquid chromatography–mass spectrometry (LC-MS) for the determination of metaxalone in human plasma has been developed and validated. Letrozole was used as the internal standard (IS). The plasma samples were simply t
Externí odkaz:
https://doaj.org/article/1b4e3b591bd840b79d6d27776026e2df
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Francesco Squadrito, Giovanni Pallio, Luigi Cardia, Giacomo Picciolo, Domenica Altavilla, Letteria Minutoli, Alessandra Bitto, Natasha Irrera, Angela D'Ascola, Federica Mannino, Violetta Squadrito
Publikováno v:
International Journal of Molecular Sciences
Volume 22
Issue 16
International Journal of Molecular Sciences, Vol 22, Iss 8425, p 8425 (2021)
Volume 22
Issue 16
International Journal of Molecular Sciences, Vol 22, Iss 8425, p 8425 (2021)
Experimental and clinical studies have suggested that several neurological disorders are associated with the occurrence of central nervous system neuroinflammation. Metaxalone is an FDA-approved muscle relaxant that has been reported to inhibit monoa
Autor:
Robert M. Levy, Masayoshi Yamaguchi
Publikováno v:
Current Molecular Medicine. 20:643-652
Backgrounds and Objective: Inflammation is implicated in the pathogenesis of many diseases. Inflammatory cytokines with painful conditions are well known as biomarkers in human muscle pain, and they are produced by macrophages. Metaxalone is used as
Autor:
Dr.Ramachandran D, N. Prasad Babu
Publikováno v:
International Journal of Applied Chemistry. 7:1-12
Publikováno v:
CrystEngComm. 22:7252-7261
In four of the five crystalline modifications of the muscle relaxants mephenoxalone 3 and metaxalone 2, chain supramolecular motifs of three different types are realized. The centrosymmetric cyclic dimer, which is considered typical of amides, was fo
Autor:
Sunil Kumar Vinubhai Gohel, Girij Pal Singh, Vasanthi Palanisamy, Palash Sanphui, Vladimir V. Chernyshev, Muthuramalingam Prakash
Publikováno v:
RSC advances. 11(49)
Muscle relaxant and pain reliever metaxalone (MET) is a biopharmaceutical classification systems (BCS) class II drug with poor aqueous solubility and high permeability. The presence of an aromatic skeleton and cyclic carboxamate moiety are the probab
Autor:
Clemencia Solorzano, E. John Gallagher, Michael P. Jones, Purvi D. Shah, Eleftheria Zias, Andrew Wollowitz, Scott Pearlman, Benjamin W. Friedman, Eddie Irizarry
Publikováno v:
Ann Emerg Med
Study objective Patients with low back pain are often treated with nonsteroidal anti-inflammatory drugs and skeletal muscle relaxants. We compare functional outcomes and pain among patients with acute low back pain who were randomized to a 1-week cou